133 related articles for article (PubMed ID: 37947435)
1. Proof of concept for monoclonal antibody therapy in a cellular model of acquired long QT syndrome type 3.
Kis L; Li J
Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H89-H95. PubMed ID: 37947435
[TBL] [Abstract][Full Text] [Related]
2. KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2.
Maguy A; Kucera JP; Wepfer JP; Forest V; Charpentier F; Li J
J Am Coll Cardiol; 2020 May; 75(17):2140-2152. PubMed ID: 32354382
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment.
Wang F; Han Y; Sang W; Wang L; Liang X; Wang L; Xing Q; Guo Y; Zhang J; Zhang L; Zukela T; Xiaokereti J; Lu Y; Zhou X; Tang B; Li Y
Cells; 2022 Aug; 11(16):. PubMed ID: 36010573
[TBL] [Abstract][Full Text] [Related]
4. Congenital long QT syndrome.
Crotti L; Celano G; Dagradi F; Schwartz PJ
Orphanet J Rare Dis; 2008 Jul; 3():18. PubMed ID: 18606002
[TBL] [Abstract][Full Text] [Related]
5. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2.
Giannetti F; Barbieri M; Shiti A; Casini S; Sager PT; Das S; Pradhananga S; Srinivasan D; Nimani S; Alerni N; Louradour J; Mura M; Gnecchi M; Brink P; Zehender M; Koren G; Zaza A; Crotti L; Wilde AAM; Schwartz PJ; Remme CA; Gepstein L; Sala L; Odening KE
Europace; 2023 May; 25(5):. PubMed ID: 37099628
[TBL] [Abstract][Full Text] [Related]
6. A personalized approach to long QT syndrome.
Etheridge SP; Asaki SY; Niu MC
Curr Opin Cardiol; 2019 Jan; 34(1):46-56. PubMed ID: 30394905
[TBL] [Abstract][Full Text] [Related]
7. Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
Moretti A; Bellin M; Welling A; Jung CB; Lam JT; Bott-Flügel L; Dorn T; Goedel A; Höhnke C; Hofmann F; Seyfarth M; Sinnecker D; Schömig A; Laugwitz KL
N Engl J Med; 2010 Oct; 363(15):1397-409. PubMed ID: 20660394
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
[TBL] [Abstract][Full Text] [Related]
9. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
[TBL] [Abstract][Full Text] [Related]
10. Insights into Cardiac IKs (KCNQ1/KCNE1) Channels Regulation.
Wu X; Larsson HP
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322401
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
[TBL] [Abstract][Full Text] [Related]
12. Induced KCNQ1 autoimmunity accelerates cardiac repolarization in rabbits: potential significance in arrhythmogenesis and antiarrhythmic therapy.
Li J; Maguy A; Duverger JE; Vigneault P; Comtois P; Shi Y; Tardif JC; Thomas D; Nattel S
Heart Rhythm; 2014 Nov; 11(11):2092-100. PubMed ID: 25087487
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
[TBL] [Abstract][Full Text] [Related]
14. Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.
Jons C; O-Uchi J; Moss AJ; Reumann M; Rice JJ; Goldenberg I; Zareba W; Wilde AA; Shimizu W; Kanters JK; McNitt S; Hofman N; Robinson JL; Lopes CM
Sci Transl Med; 2011 Mar; 3(76):76ra28. PubMed ID: 21451124
[TBL] [Abstract][Full Text] [Related]
15. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death.
Chen S; Zhang L; Bryant RM; Vincent GM; Flippin M; Lee JC; Brown E; Zimmerman F; Rozich R; Szafranski P; Oberti C; Sterba R; Marangi D; Tchou PJ; Chung MK; Wang Q
Clin Genet; 2003 Apr; 63(4):273-82. PubMed ID: 12702160
[TBL] [Abstract][Full Text] [Related]
16. Modelling the long QT syndrome with induced pluripotent stem cells.
Itzhaki I; Maizels L; Huber I; Zwi-Dantsis L; Caspi O; Winterstern A; Feldman O; Gepstein A; Arbel G; Hammerman H; Boulos M; Gepstein L
Nature; 2011 Mar; 471(7337):225-9. PubMed ID: 21240260
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome.
Jiang Y; Du W; Chu Q; Qin Y; Tuguzbaeva G; Wang H; Li A; Li G; Li Y; Chai L; Yue E; Sun X; Wang Z; Pavlov V; Yang B; Bai Y
Cell Physiol Biochem; 2018; 45(1):192-202. PubMed ID: 29339628
[TBL] [Abstract][Full Text] [Related]
18. KCNQ1 G219E and TRPM4 T160M polymorphisms are involved in the pathogenesis of long QT syndrome: A case report.
Zhao Y; Feng M; Shang LX; Sun HX; Zhou XH; Lu YM; Zhang L; Xing Q; Li YD; Tang BP
Medicine (Baltimore); 2021 Jan; 100(2):e24032. PubMed ID: 33466149
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
Antzelevitch C
J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
[TBL] [Abstract][Full Text] [Related]
20. Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.
Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
Biochim Biophys Acta; 2011 Apr; 1812(4):488-94. PubMed ID: 21241800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
